Coulter Partners secures key transatlantic Board appointments for Compass Pathways

Compass Pathways is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. Dr. Jonas brings more than three decades of leadership in central nervous system (CNS) drug development and neuroscience research, while Ms. Tregoning adds deep expertise in global market access, public policy, and biopharmaceutical growth strategy.